NITRIC OXIDE AND MACROPHAGE FUNCTION

Annual Review of Immunology - Tập 15 Số 1 - Trang 323-350 - 1997
John D. MacMicking1, Q W Xie1, Carl Nathan1
1Beatrice and Samuel A. Seaver Laboratory, Department of Medicine, Cornell University Medical College, New York, NY 10021;

Tóm tắt

▪ Abstract  At the interface between the innate and adaptive immune systems lies the high-output isoform of nitric oxide synthase (NOS2 or iNOS). This remarkable molecular machine requires at least 17 binding reactions to assemble a functional dimer. Sustained catalysis results from the ability of NOS2 to attach calmodulin without dependence on elevated Ca2+. Expression of NOS2 in macrophages is controlled by cytokines and microbial products, primarily by transcriptional induction. NOS2 has been documented in macrophages from human, horse, cow, goat, sheep, rat, mouse, and chicken. Human NOS2 is most readily observed in monocytes or macrophages from patients with infectious or inflammatory diseases. Sustained production of NO endows macrophages with cytostatic or cytotoxic activity against viruses, bacteria, fungi, protozoa, helminths, and tumor cells. The antimicrobial and cytotoxic actions of NO are enhanced by other macrophage products such as acid, glutathione, cysteine, hydrogen peroxide, or superoxide. Although the high-output NO pathway probably evolved to protect the host from infection, suppressive effects on lymphocyte proliferation and damage to other normal host cells confer upon NOS2 the same protective/destructive duality inherent in every other major component of the immune response.

Từ khóa


Tài liệu tham khảo

Prout W, 1818, London Medico-Chirugical Transactions, 9, 472

10.1073/pnas.78.12.7764

10.1126/science.6451927

10.1073/pnas.82.22.7738

10.1093/carcin/8.7.955

10.1126/science.2432665

10.1038/327524a0

10.1073/pnas.84.24.9265

10.1074/jbc.271.20.11911

10.1016/0014-5793(95)00439-G

10.1098/rstb.1991.0102

10.1111/j.1460-9568.1994.tb00327.x

10.1126/science.8386393

10.1074/jbc.270.28.16576

10.1084/jem.182.3.677

10.1042/bj3040105

Moncada S, 1991, Pharmacol. Rev., 43, 109

10.1096/fasebj.6.12.1381691

10.1016/0952-7915(91)90079-G

Nathan C, 1994, J. Biol. Chem., 269, 13725, 10.1016/S0021-9258(17)36703-0

10.1146/annurev.bi.63.070194.001135

James SL, 1995, Microbiol. Rev., 59, 533, 10.1128/mr.59.4.533-547.1995

Michel T, Xie Q-w, Nathan C. 1996.Molecular biological analysis of nitric oxide synthases.InMethods in Nitric Oxide Research, ed. M Feelisch, JS Stamler, pp. 161–75, Chichester: Wiley & Sons

10.1146/annurev.ph.57.030195.003513

10.1146/annurev.ph.57.030195.003423

10.1515/bchm3.1995.376.3.179

10.1093/clinids/21.Supplement_2.S162

Stamler JS, 1996, Curr. Top. Microbiol. Immunol., 196, 19

10.1016/0092-8674(94)90005-1

10.1126/science.1373522

10.1073/pnas.92.20.9072

10.1096/fasebj.10.5.8621055

Xie Q-w, 1994, J. Biol. Chem., 269, 28500, 10.1016/S0021-9258(18)46955-4

10.1073/pnas.93.10.4891

10.1073/pnas.92.25.11514

10.1074/jbc.271.12.6789

10.1038/351714a0

10.1073/pnas.92.25.11771

10.1074/jbc.271.10.5414

Vodovotz Y, 1994, J. Immunol., 152, 4110, 10.4049/jimmunol.152.8.4110

10.1084/jem.176.2.599

Zhang M, 1994, J. Biol. Chem., 269, 981, 10.1016/S0021-9258(17)42208-3

10.1021/bi00074a020

10.1074/jbc.271.11.6435

10.1021/bi00003a013

Sheta EA, 1994, J. Biol. Chem., 269, 15147, 10.1016/S0021-9258(17)36585-7

10.1016/0014-5793(95)01496-9

Abu-Soud HM, 1994, J. Biol. Chem., 269, 32047, 10.1016/S0021-9258(18)31597-7

10.1073/pnas.90.22.10769

10.1165/ajrcmb/9.4.371

10.1073/pnas.92.17.7809

10.1172/JCI118339

10.1016/0165-2478(94)00158-8

Riches DW, 1991, J. Biol. Chem., 266, 24785, 10.1016/S0021-9258(18)54298-8

10.1126/science.8456300

10.1126/science.8456301

10.1074/jbc.271.1.337

10.1083/jcb.129.6.1651

10.1074/jbc.271.23.13776

Xie Q-w, Nathan C. 1993.Promoter of the mouse gene encoding calcium-independent nitric oxide synthase confers inducibility by interferon-γ and bacterial lipopolysaccharide.InTransactions of the Association of American Physicians, 106:1–12. Baltimore: Waverly

10.1096/fasebj.7.2.8440413

10.1002/jlb.58.6.725

Kim H, 1995, J. Immunol., 154, 4741, 10.4049/jimmunol.154.9.4741

10.1084/jem.177.6.1779

10.1073/pnas.90.20.9730

10.1073/pnas.93.3.1054

10.1074/jbc.270.30.17917

Xie Q-w, 1994, J. Biol. Chem., 269, 4705, 10.1016/S0021-9258(17)37600-7

10.1073/pnas.93.8.3308

10.1126/science.7510419

10.1084/jem.180.3.977

10.1084/jem.182.6.1683

10.1074/jbc.271.13.7412

10.1073/pnas.93.1.255

10.1002/jlb.55.2.227

10.1084/jem.174.6.1549

10.1073/pnas.89.18.8676

10.1016/0014-5793(95)00284-G

Wang MH, 1994, J. Biol. Chem., 269, 14027, 10.1016/S0021-9258(17)36750-9

Griscavage JM, 1993, J. Immunol., 151, 6329, 10.4049/jimmunol.151.11.6329

10.1016/0955-2235(94)00004-5

10.1084/jem.183.5.2337

10.1073/pnas.93.5.2054

Perrella MA, 1994, J. Biol. Chem., 269, 14595, 10.1016/S0021-9258(17)36665-6

Vodovotz Y, 1995, J. Immunol., 154, 2914, 10.4049/jimmunol.154.6.2914

Shaul PW, 1996, Proc. Natl. Acad. Sci. USA, 271, 6518

10.1002/jlb.49.4.380

10.1084/jem.183.5.2293

10.1016/0168-8278(92)90150-N

10.1084/jem.184.2.557

Clair E, 1996, J. Exp. Med.

MacMicking JD, North RJ, LaCourse R, Mudgett JS, Shah S, Nathan CF. 1996. Identification of NOS2 as a protective locus against tuberculosis. Submitted

Weinberg J, 1993, Blood, 82, 186a

10.1073/pnas.92.17.7804

Adler H, 1995, J. Immunol., 154, 4710, 10.4049/jimmunol.154.9.4710

Jungi TW, Adler H, Adler B, Pfister H, Brcic M, Thony M, Tipold A, Zurbriggen A, Fatzer R, Pauli U, Peterhans E. 1996.Regulation of inducible nitric oxide synthase in ungulate mononuclear phagocytes. Presented at FASEB Res. Conf. on Principles in Viral, Bacterial, Fungal and Protozoan Pathogenesis, Snowmass, CO

10.1016/0035-9203(83)90190-6

10.1126/science.7690156

Lane TE, 1994, Infect. Immun., 62, 1478, 10.1128/iai.62.4.1478-1479.1994

10.1002/eji.1830211216

10.1084/jem.180.3.783

10.1084/jem.183.4.1501

Goldman D, 1996, Am. J. Pathol., 148, 1275

Yoshida A, 1995, J. Immunol., 155, 2057, 10.4049/jimmunol.155.4.2057

10.1073/pnas.90.7.3024

Campbell IL, 1994, J. Immunol., 153, 3622, 10.4049/jimmunol.153.8.3622

Liew FY, 1990, J. Immunol., 144, 4794, 10.4049/jimmunol.144.12.4794

Evans TG, 1993, J. Immunol., 151, 907, 10.4049/jimmunol.151.2.907

10.1002/eji.1830230417

10.1126/science.8100366

10.1006/viro.1996.0141

Boockvar KS, 1994, Infect. Immun., 62, 1089, 10.1128/iai.62.3.1089-1100.1994

10.1165/ajrcmb.13.1.7598935

Vespa GNR, 1994, Infect. Immun., 62, 5177, 10.1128/iai.62.11.5177-5182.1994

Chan J, 1995, Infect. Immun., 63, 736, 10.1128/iai.63.2.736-740.1995

10.1172/JCI118613

Beckerman KP, 1993, J. Immunol., 150, 888, 10.4049/jimmunol.150.3.888

10.1084/jem.180.1.353

10.1002/jlb.58.1.23

Wynn TA, 1994, J. Immunol., 153, 5200, 10.4049/jimmunol.153.11.5200

Hayashi S, 1996, J. Immunol., 156, 1476, 10.4049/jimmunol.156.4.1476

10.1016/0014-2999(95)00618-4

Akarid K, 1995, J. Virol., 69, 7001, 10.1128/jvi.69.11.7001-7005.1995

Tucker PC, 1996, J. Virol., 70, 3972, 10.1128/jvi.70.6.3972-3977.1996

Gregory SH, 1993, J. Immunol., 150, 2901, 10.4049/jimmunol.150.7.2901

10.1073/pnas.93.6.2448

10.1006/viro.1996.0252

Sternberg J, 1994, Infect. Immun., 62, 2135, 10.1128/iai.62.5.2135-2137.1994

Vincendeau P, 1991, J. Immunol., 146, 4338, 10.4049/jimmunol.146.12.4338

10.1126/science.1948068

10.1038/147417b0

Shank JL, 1962, Appl. Microbiol., 101, 185, 10.1128/am.10.3.185-189.1962

10.1002/jlb.49.1.73

Flesch IEA, 1991, Infect. Immun., 59, 3213, 10.1128/iai.59.9.3213-3218.1991

10.1084/jem.175.4.1111

O'Brien L, 1994, Infect. Immun., 62, 5187, 10.1128/iai.62.11.5187-5190.1994

Doi T, 1993, Infect. Immun., 61, 1980, 10.1128/iai.61.5.1980-1989.1993

Incze K, 1974, Appl. Microbiol., 27, 202, 10.1128/am.27.1.202-205.1974

Moran DM, 1975, Appl. Microbiol., 30, 838, 10.1128/am.30.5.838-843.1975

Rockett KA, 1991, Infect. Immun., 59, 3280, 10.1128/iai.59.9.3280-3283.1991

10.1073/pnas.92.14.6399

10.1126/science.272.5260.414

10.1172/JCI116479

Bi Z, 1995, J. Virol., 69, 2208, 10.1128/jvi.69.4.2208-2213.1995

10.1016/0891-5849(93)90084-8

10.1084/jem.182.5.1469

Melkova Z, 1995, J. Immunol., 155, 5711, 10.4049/jimmunol.155.12.5711

10.1084/jem.181.6.2171

10.1084/jem.169.5.1543

10.1016/0092-8674(95)90019-5

10.1126/science.8303277

10.1021/jm00115a013

10.1084/jem.146.6.1648

Klebanoff SJ. 1992.Oxygen metabolites from phagocytes.InInflammation: Basic Principles and Clinical Correlates, ed. JI Gallin, IM Goldstein, R Snyderman, pp. 541–88. New York: Raven

10.1038/327524a0

10.1073/pnas.87.4.1620

Hausladen A, 1994, J. Biol. Chem., 269, 29405, 10.1016/S0021-9258(18)43893-8

10.1073/pnas.93.5.1776

10.1016/0092-8674(95)90085-3

10.1038/375408a0

10.1073/pnas.92.23.10688

10.1016/1074-7613(95)90001-2

Nunoshiba T, 1995, Infect. Immun., 63, 794, 10.1128/iai.63.3.794-798.1995

Duerksen-Hughes PJ, 1992, J. Immunol., 149, 2114, 10.4049/jimmunol.149.6.2114

Cox G, 1992, J. Immunol., 149, 3290, 10.4049/jimmunol.149.10.3290

10.1084/jem.181.4.1333

Martin JHJ, 1993, J. Immunol., 150, 3478, 10.4049/jimmunol.150.8.3478

10.1016/0923-2494(93)80105-8

10.1016/0092-8674(95)90418-2

10.1084/jem.153.4.766

Yim C-Y, 1993, Cancer Res., 53, 5507

10.1073/pnas.91.20.9407

10.1073/pnas.92.10.4392

10.1074/jbc.271.11.6144

Ding A, 1990, J. Immunol., 145, 940, 10.4049/jimmunol.145.3.940

10.1084/jem.180.3.945

10.1084/jem.183.4.1323

Hoffman RA, 1990, J. Immunol., 145, 2220, 10.4049/jimmunol.145.7.2220

Mills CD, 1991, J. Immunol., 146, 2719, 10.4049/jimmunol.146.8.2719

Albina JE, 1991, J. Immunol., 147, 144, 10.4049/jimmunol.147.1.144

10.1084/jem.180.3.1153

Matthys P, 1995, J. Immunol., 155, 3823, 10.4049/jimmunol.155.8.3823

Lander HM, 1993, J. Immunol., 150, 1509, 10.4049/jimmunol.150.4.1509

Sriskandan S, 1996, J. Immunol., 156, 2430, 10.4049/jimmunol.156.7.2430

10.1084/jem.177.2.397

10.1084/jem.174.5.1009

Sicher SC, 1994, J. Immunol., 153, 1293, 10.4049/jimmunol.153.3.1293

Zingarelli B, 1996, J. Immunol., 156, 350, 10.4049/jimmunol.156.1.350

Albina JE, 1993, J. Immunol., 150, 5080, 10.4049/jimmunol.150.11.5080

10.1016/0014-5793(94)01161-3